S&P 500 7,659.44 −1.09%
Nasdaq 26,140.03 −2.15%
S&P/TSX 36,176.55 +0.11%
Apple 343.46 +0.15%
Nvidia 214.13 −3.24%
Microsoft 529.05 −0.87%
Shopify 239.71 −5.08%
Royal Bank 280.01 +0.36%
CAD/USD 0.7074 +0.40%
CLOSED · 21:05 ET
Market ClerkRecap
Fri Oct 16 · markets closed3 signals today60 insider buys this week · $61.1MCIRO short report next: Oct 31The week ahead
KT
INSIDER · AGMB · AgomAb Therapeutics NV · CHIEF EXECUTIVE OFFICER

Knotnerus Tim Jasper

Every open-market transaction filed under this name, Oct 5 to Oct 6.

Filings
2
2 buys · 0 sells
Bought
$94K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−3.0%
avg move from buy price, 2 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 6AGMBAgomAb Therapeutics NVChief Executive OfficerBuy5,000$8.70$44K−4.3%
Oct 5AGMBAgomAb Therapeutics NVChief Executive OfficerBuy6,000$8.48$51K−1.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.